Mazdutide

Product Details – Mazdutide

Mazdutide is a synthetic peptide composed of 33 amino acids linked through peptide bonds. It is classified as a dual receptor agonist and is studied in controlled research environments for its interaction with glucagon-like peptide-1 receptors (GLP-1R) and glucagon receptors (GCGR).

Within laboratory settings, mazdutide is utilized to investigate receptor-ligand binding behavior and signaling pathway modulation. Its dual receptor interaction profile allows for detailed examination of multiple receptor-mediated processes at the molecular level.

This compound is supplied strictly for laboratory research purposes and is not intended for consumption, medical, or diagnostic use.

Mechanism of Action

At the molecular level, mazdutide is studied for its interaction with GLP-1 receptors and glucagon receptors, both of which belong to the G protein-coupled receptor (GPCR) family. Upon binding, the compound-receptor complex initiates intracellular signaling cascades associated with cyclic adenosine monophosphate (cAMP) production and downstream transcriptional activity.

This dual receptor engagement is analyzed in vitro to evaluate receptor activation, ligand-binding affinity, and signaling pathway integration. Researchers examine how simultaneous receptor interaction influences intracellular communication and regulatory signaling networks.

Additionally, mazdutide is investigated for its role in modulating receptor-specific signaling pathways, including those associated with metabolic regulation and peptide-mediated cellular responses, under controlled experimental conditions.

Chemical Properties of Mazdutide

Attribute	Details
Compound Name	Mazdutide
Classification	Dual GLP-1R / GCGR agonist peptide
Molecular Formula	C207H317N45O65
Molecular Weight	4476 g/mol
CAS Number	2259884-03-0
PubChem CID	167312357
Synonyms	IBI-362; IBI362
Primary Target	GLP-1 receptor (GLP-1R); Glucagon receptor (GCGR)
Research Context	Dual receptor signaling and pathway modulation studies
Format	Research peptide (non-consumable)
Stability	Maintained under controlled laboratory storage conditions

Research Applications

Dual Receptor Binding Studies

Mazdutide is utilized in experimental systems to analyze ligand interaction with both GLP-1 and glucagon receptors. Researchers evaluate receptor activation, binding affinity, and signaling coordination at the molecular level.

Intracellular Signaling Pathway Analysis

This compound is applied in studies examining GPCR-mediated signaling cascades, including second messenger systems such as cAMP. These investigations focus on downstream transcriptional and regulatory processes.

Peptide-Receptor Interaction Research

Mazdutide supports investigations into how dual receptor agonists influence signaling dynamics and receptor selectivity. These studies contribute to a broader understanding of multi-target ligand behavior.

Why Choose BehemothLabz to Buy Mazdutide for Research

BehemothLabz supplies research-grade Mazdutide produced under controlled laboratory conditions with strict quality assurance protocols in place. Each batch undergoes detailed analytical verification to ensure consistency in molecular composition and purity.

In addition, comprehensive documentation, including laboratory testing reports and sourcing transparency, supports reproducibility across experimental applications. BehemothLabz maintains a compliance-focused approach, ensuring that all compounds are supplied exclusively for laboratory-based investigation and analytical research.

Disclaimer

Mazdutide is intended strictly for laboratory research and analytical purposes only. It is not designed for diagnostic procedures, therapeutic applications, or any form of in vivo study.

All references to biochemical pathways, receptor interactions, and enzymatic processes are provided solely within a research context. This compound must be handled only by qualified professionals within controlled laboratory environments, in accordance with applicable regulations and safety standards.

Any use outside of these defined research conditions is strictly prohibited.

References

• Zhang, B., Cheng, Z., Chen, J., Zhang, X., Liu, D., Jiang, H., Ma, G., Wang, X., Gan, S., Sun, J., Jin, P., Yi, J., Shi, B., Ma, J., Ye, S., Wang, G., Ji, L., Gu, X., Yu, T., An, P., … Yang, W. (2024). Efficacy and Safety of Mazdutide in Chinese Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial. Diabetes care, 47(1), 160–168. https://doi.org/10.2337/dc23-1287
• Dong, W., Bai, J., Yuan, Q., Zhang, Y., Zhang, Y., Zhang, Z., Yang, M., Li, H., Zhao, Z., & Jiang, H. (2025). Mazdutide, a dual agonist targeting GLP-1R and GCGR, mitigates diabetes-associated cognitive dysfunction: mechanistic insights from multi-omics analysis. EBioMedicine, 117, 105791. https://doi.org/10.1016/j.ebiom.2025.105791